APRIL 10, 2026

Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy? | The Motley Fool

Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy? | The Motley Fool

Summary

Investors are shifting from high-flying AI stocks to safer options like healthcare and retail amid economic uncertainties. Moderna has surged nearly 70% this year as it pivots towards growth with a focus on seasonal vaccines and oncology, while Target has also seen significant gains. Both stocks present potential buying opportunities, particularly on dips, as they adapt to changing market conditions and consumer needs.



Disclosure: This article is for informational and educational purposes only and is not financial, investment, tax, or legal advice. References to specific securities, tickers, companies, or strategies are provided for informational purposes only and do not constitute a recommendation, solicitation, or offer to buy or sell any security or financial product. We do not provide individualized advice or act as a fiduciary. Investing involves risk, including loss of principal, and past performance is not indicative of future results. We may hold positions in securities mentioned. You should independently verify information before acting on it and consult a qualified professional as needed.